The Potential Drug Target and Biomarker ARF4: Unlocking the Functions of ADP Ribosylation Factor 4

Target Name: ARF4

NCBI ID: G378

ARF4

Other Name(s): ADP ribosylation factor 4 | ARF4_HUMAN | ADP-ribosylation factor 4 | ARF2 | ADP-ribosylation factor 2

The Potential Drug Target and Biomarker ARF4: Unlocking the Functions of ADP Ribosylation Factor 4

Introduction

ARF4, a protein known as ADP ribosylation factor 4, is a crucial enzyme in the ribosome biogenesis pathway. In vivo, ARF4 is involved in protein synthesis and plays a key role in this process. At the same time, ARF4 is also a potential drug target. This article will describe the function of ARF4, its possibility as a drug target, and current research progress.

1. Functions of ARF4

ARF4 is a ribosome-binding protein that is responsible for pairing amino acids on tRNA on the ribosome with codons on the mRNA during protein synthesis. This process is called translation. The efficient function of ARF4 makes it play an important role in protein synthesis in vivo. In cells, ARF4 is mainly distributed in the cytoplasm, endoplasmic reticulum, and Golgi apparatus. In addition, ARF4 also plays an important role in the nucleus and is involved in the structure and function of chromatin.

2. The possibility of ARF4 as a drug target

1. The mechanism of ARF4 as a drug target

ARF4, as a protein, is of high value in the drug development process. First, ARF4, as a protein, has high functionality, which greatly increases the possibility of it becoming a drug target. In addition, ARF4 has a unique structure, which makes it a possible drug target.

2. Advantages of ARF4 as a drug target

(1) Good therapeutic effect: Since ARF4 is involved in the protein synthesis process, many diseases, such as cancer, diabetes, etc., can be effectively treated by inhibiting the function of ARF4.

(2) Durable therapeutic effect: Unlike traditional drugs, ARF4 has a sustained therapeutic effect as a drug target. Once ARF4 function is inhibited, therapeutic effects can last for a long time.

(3) Less side effects: Since ARF4 is mainly distributed in the cytoplasm, inhibiting the function of ARF4 has less impact on the normal physiological functions of cells, thereby reducing the side effects of the drug.

3. Risks of ARF4 as a drug target

Although ARF4 has great potential as a drug target, it also carries certain risks. First of all, ARF4 is a protein that widely exists in the body. Therefore, inhibiting the function of ARF4 may have an impact on other tissues and organs of the body and increase the side effects of drugs.

Secondly, ARF4 plays an important role in many organisms, and inhibiting the function of ARF4 may have irreversible effects on the normal physiological functions of organisms, leading to serious consequences.

3. ARF4 research progress

Currently, researchers are studying the function of ARF4 in depth to discover its potential as a drug target. At the same time, researchers are constantly exploring the structure of ARF4 to better understand its function and potential as a drug target.

1. In-depth study of ARF4 functions

Currently, researchers are studying the function of ARF4 in vivo in order to discover its potential as a drug target. For example, researchers are studying the role of ARF4 in tumor development and progression and exploring ARF4 as a target for tumor treatment.

2. Study on the structure of ARF4

To better understand the function of ARF4, researchers are continuing to explore the structure of ARF4. Currently, researchers have discovered multiple functional subunits of ARF4 and conducted in-depth studies of their roles in the protein synthesis process. These studies provide important clues for in-depth understanding of the function of ARF4.

4. Conclusion

As a ribosome-binding protein, ARF4 has important physiological functions in organisms. At the same time, ARF4 is also a potential drug target. Currently, researchers are studying the function of ARF4 in depth to discover its potential as a drug target. Although ARF4 has high nutritional value as a protein, at the same time

Protein Name: ADP Ribosylation Factor 4

Functions: GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus

The "ARF4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARF4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets